Mitolactol January 19, 2018 Mitolactol Trade Name Orphan Indication As adjuvant therapy in the treatment of primary brain tumors USA Market Approval USA USA Designation Date 1995-07-12 00:00:00 Sponsor Targent, Inc.;155 Lambert Drive;Princeton, New Jersey, 08540
